This is not the most recent version of the article. View current version (8 DEC 2010)

Intervention Protocol

Vitamin D for the management of multiple sclerosis

  1. Vanitha A Jagannath1,*,
  2. Zbys Fedorowicz2,
  3. G V Asokan3,
  4. Edward W Robak4,
  5. Liz Whamond5

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 1 NOV 2009

DOI: 10.1002/14651858.CD008422


How to Cite

Jagannath VA, Fedorowicz Z, Asokan GV, Robak EW, Whamond L. Vitamin D for the management of multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD008422. DOI: 10.1002/14651858.CD008422.

Author Information

  1. 1

    KIMS Bahrain Medical Center, Department of Paediatrics, Manama, Bahrain

  2. 2

    Ministry of Health, Bahrain, UKCC (Bahrain Branch), Awali, Bahrain

  3. 3

    Institute of Veterinary Preventive Medicine, Ranipet, Tamil Nadu, India

  4. 4

    University of New Brunswick, Faculty of Forestry and Environmental Management, Fredericton, NB, Canada

  5. 5

    Canadian Cancer Action Network, Fredericton, NB, Canada

*Vanitha A Jagannath, Department of Paediatrics, KIMS Bahrain Medical Center, Um al Hassam Ave, Adliya, Manama, PO Box 175829, Bahrain. kidzdoc311@gmail.com. kidzdoc311@yahoo.co.in.

Publication History

  1. Publication Status: New
  2. Published Online: 17 MAR 2010

SEARCH

This is not the most recent version of the article. View current version (08 DEC 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the safety and effectiveness of vitamin D in the management of multiple sclerosis (MS)

To evaluate the hypotheses that vitamin D supplementation reduces the MS disease activity and suppresses disease progression, prevents development of osteoporosis and promotes T cell regulation in people of MS